Lin Patrick

Chief Business - Strategy Off

1 company

Weak

Trades Analyzed

12M Win Rate

0.0%

Avg 3M Return

-5.1%

Avg 12M Return

-68.2%

Lin Patrick is a Chief Business - Strategy Off at Processa Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 12 buys and 0 sells.

Estimated insider holdings value: $119K based on current market prices.

Holdings by Company

PCSAApr 1, 2025

Current Shares43.5K

Value$118.9K

Net Activity+98.3K

Bought: 98.3KSold: 0

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 27, 2025	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	43,500	$0.80	$34,691.25	New	-61.5%	-79.1%
Feb 1, 2024	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	4,000	$2.38	$9,525.00	+8.1%	-5.1%	-72.2%
May 17, 2022	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	2,000	$1.59	$3,189.00	+0.5%	+72.5%	-65.1%
Apr 7, 2022	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	2,000	$3.29	$6,587.08	+0.2%	-7.9%	-86.8%
Dec 14, 2021	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	3,000	$4.00	$12,000.00	+0.7%	-12.7%	-51.1%
Dec 14, 2021	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	3,000	$4.00	$12,000.00	+0.7%	-12.7%	-51.1%
Dec 3, 2021	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	3,500	$4.80	$16,795.10	+0.8%	-18.9%	-60.3%
Aug 26, 2021	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	4,000	$6.02	$24,088.00	+1.0%	-5.5%	-50.4%
Jun 21, 2021	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	2,000	$6.65	$13,300.00	+0.5%	+4.7%	-59.5%
Oct 1, 2020	PCSA Processa Pharmaceuticals, Inc.	Chief Business - Strategy Off	Buy	31,250	$2.10	$65,625.00	+8.5%	-	-